Align Technology (ALGN) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0162551016

(NASDAQ:ALGN Stock) Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; and non-case products that include retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment. The Systems and Services segment offers iTero intraoral scanning system, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, and pay per scan services Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Align Technology (ALGN) - Stock Price & Dividends

ALGN Stock Overview

Market Cap in USD 22,699m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Supplies
TER 0.00%
IPO / Inception 2001-01-26

ALGN Stock Ratings

Fundamental 5.04
Dividend -
Growth 5y 0.20
Rel. Performance vs Sector -1.40
Analysts 4.00
Fair Price Total Ret. 274.12
Fair Price DCF 167.78

ALGN Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

ALGN Growth Ratios

Growth 12m 0.64%
Growth Correlation 12m -32%
Growth Correlation 3m 67%
CAGR 5y 3.03%
CAGR / Mean Drawdown 0.09
Sharpe Ratio 12m -0.10
Alpha vs SP500 12m -39.04
Beta vs SP500 5y weekly 1.61
CAPM 9.70%
Average Daily Range 2m 3.59%
Regime Oscillator 79.68
Volatility GJR Garch 1y 51.49%
Price / SMA 50 12.25%
Price / SMA 200 4.16%
Current Volume 920.6k
Average Volume 20d 1168.5k

External Links for ALGN Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of ALGN stocks?
As of February 22, 2024, the stock is trading at USD 304.65 with a total of 920,636 shares traded.
Over the past week, the price has changed by +0.63%, over one month by +12.16%, over three months by +41.50% and over the past year by +0.21%.
Why is ALGN stock down?
Check with which Index or Commodity ALGN has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return ALGN Return S&P 500
1 Month 12.16% 2.85%
3 Months 41.50% 10.14%
12 Months 0.21% 26.48%
What is the forecast for ALGN stock price target?
According to ValueRays Forecast Model, ALGN Align Technology will be worth about 305.1 in February 2025. The stock is currently trading at 304.65. This means that the stock has a potential upside of +0.16%.
Issuer Forecast Upside
Wallstreet Target Price 306.2 0.5%
Analysts Target Price 270.4 -11.2%
ValueRay Target Price 305.1 0.2%